Michaël Broux
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 2
-
- Histone Deacetylase Inhibitors Research 2
- Ubiquitin and proteasome pathways 1
- Epigenetics and DNA Methylation 1
- Co-authors
- Sofie Demeyer (6 shared papers)Jan Cools (6 shared papers)Ellen Geerdens (4 shared papers)Peter Vandenberghe (2 shared papers)Carmen Vicente (2 shared papers)Llucia Albertí Servera (2 shared papers)Jolien De Bie (2 shared papers)Marlies Vanden Bempt (3 shared papers)
- Journals
- Cancer Cell (1 paper)iScience (1 paper)Leukemia (1 paper)Blood (1 paper)Haematologica (1 paper)
- Partner nations
- BelgiumSwitzerlandUnited States
In The Last Decade
Michaël Broux
6 papers receiving 287 citations
Peers
Comparison fields: 5 of 31
- Hematology 108
- Public Health, Environmental and Occupational Health 128
- Cancer Research 48
- Genetics 30
- Pathology and Forensic Medicine 44
Countries citing papers authored by Michaël Broux
This map shows the geographic impact of Michaël Broux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Broux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Broux more than expected).
Fields of papers citing papers by Michaël Broux
This network shows the impact of papers produced by Michaël Broux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Broux. The network helps show where Michaël Broux may publish in the future.
Co-authors
The 25 scholars most cited alongside Michaël Broux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 118 | |
| 2 | 2018 | 67 | |
| 3 | 2018 | 42 | |
| 4 | 2019 | 34 | |
| 5 | 2021 | 21 | |
| 6 | 2022 | 8 |
About Michaël Broux
Michaël Broux is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Immunology and Pathology and Forensic Medicine, having authored 6 papers that have together received 290 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), T-cell and Retrovirus Studies (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer Genomics and Diagnostics (1 paper), Ubiquitin and proteasome pathways (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Hematology (108 citations), Public Health, Environmental and Occupational Health (128 citations), Cancer Research (48 citations), Genetics (30 citations) and Pathology and Forensic Medicine (44 citations). Michaël Broux has collaborated with scholars based in Belgium, Switzerland and United States. Frequent co-authors include Sofie Demeyer, Jan Cools, Ellen Geerdens, Peter Vandenberghe, Carmen Vicente, Llucia Albertí Servera, Jolien De Bie, Marlies Vanden Bempt, Ajay Vora and Nicole Mentens. Their work appears in journals such as Cancer Cell, iScience, Leukemia, Blood and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.